Improving cancer diagnosis to better identify aggressive cases
Official title: Analytic diagnosis methods for disease ruling
Funded at Emory University · NIH-10882230 · Data updated 2026-11-12
This study is working on better ways to diagnose prostate cancer so that doctors can tell the difference between serious and less serious cases, helping patients get the right treatment without unnecessary tests.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $346,124 |
| NIH project number | 1R01CA283687-01A1 |
| Project ID | NIH-10882230 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at risk for prostate cancer, particularly those with intermediate to high-risk factors.
✕Less likely to help
Patients with low-risk prostate cancer who are not candidates for aggressive treatment may not benefit from this research.
What this research studies
This research focuses on enhancing the methods used to diagnose cancer, particularly prostate cancer, by developing new analytic frameworks that help distinguish between aggressive and low-risk cases. The project aims to create a performance metric that directly relates to clinical utility, which will guide medical decision-making. By employing advanced statistical and computational techniques, the research seeks to formulate diagnostic rules that can accurately assess cancer risk while minimizing unnecessary procedures like biopsies. Patients will benefit from more precise diagnoses that can lead to better treatment decisions.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cancer diagnoses, reducing unnecessary treatments and improving patient outcomes.
How similar studies have gone: Previous research has shown promise in developing analytic methods for cancer diagnosis, indicating that this approach could yield significant advancements.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Huang, Yijian — Emory University
- Study coordinator: Huang, Yijian
Related research
Other NIH-funded projects on the same topics.
-
Administrative and Engagement Core for Breast Cancer Breakthrough in Kenya
A national effort in Kenya to speed up how we screen for breast cancer and connect women to treatment, using teamwork across institutions.
-
Collaborative research program to advance patient care
A multi-project research effort at Emory University aims to push forward medical knowledge that could help people with illnesses in the future.
-
Project-003: A multi-partner research program at Emory University
A multi-faceted NIH grant at Emory University aims to advance understanding in a focused area over several years to benefit patients with diseases or conditions connected to the research.
-
Project-002: advancing patient care through coordinated research at Emory
A multi-project NIH grant at Emory aims to translate findings into better care for people with a health condition by coordinating research efforts across teams.
-
Project-006: A Multidisciplinary Emory Initiative to Advance Medical Understanding
A multi-project NIH grant at Emory University aims to push forward medical knowledge in areas that could eventually help patients.
-
Project-005: A multi-component research effort at Emory University
A multi-part NIH grant from Emory University aims to advance understanding in a specific health area over several years with potential patient benefits in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.